<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132707">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01775878</url>
  </required_header>
  <id_info>
    <org_study_id>CN-08JMink-01</org_study_id>
    <nct_id>NCT01775878</nct_id>
  </id_info>
  <brief_title>Diabetes Care Management Trial of Telemetric Monitoring</brief_title>
  <acronym>TELEGAP</acronym>
  <official_title>A Randomized Study Comparing Usual Diabetes Care Management to Telemetric Home-based Monitoring of Glucose and Blood Pressure in Patients With Diabetes (TELEGAP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Samsung Electronics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a two-arm, parallel-comparison, single-blind, randomized controlled trial, and
      will be offered to Kaiser Permanente members aged 18 - 75 years old who present to the Santa
      Rosa Diabetes Care Management Center with Type 2 diabetes mellitus. Participants will be
      randomly assigned to one of two treatment arms. The telemedicine group or the group
      receiving usual care (the control group).

      This study hopes to show the usefulness of this telemonitoring technology and more
      specifically, to assess whether this device improves markers of control of diabetes,
      glycemic control, and cardiovascular risk factors
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Fructosamine</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change from baseline to 6 weeks in serum fructosamine levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>glycosylated hemoglobin</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>change from baseline to 6 months in serum HbA1c levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>6 weeks and 6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>goal of systolic &lt; 130 mmHg and diastolic &lt; 70 mmHg</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">254</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This arm received usual care from the diabetes care managers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telemonitoring Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm received a telemonitoring device installed in their homes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telemonitoring Device</intervention_name>
    <description>Telemonitoring device was installed in patients' homes</description>
    <arm_group_label>Telemonitoring Device</arm_group_label>
    <other_name>Samsung Health Diary</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 - 75 years old,

          -  diagnosis of type 2 diabetes mellitus for at least 1 month,

          -  eligible for and referred to the diabetes care management program,

          -  HbA1c values in the range: 7.5% to 10.5%.

        Exclusion Criteria:

          -  Weight &gt; 330 lbs,

          -  estimated glomerular filtration rate (GFR) &lt; 45,

          -  unstable coronary artery disease,

          -  severe peripheral vascular disease which restricted exercise,

          -  end-stage liver disease,

          -  undergoing treatment for cancer,

          -  pregnant or not using appropriate birth control,

          -  no broadband internet access in their homes.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerry Minkoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 23, 2013</lastchanged_date>
  <firstreceived_date>January 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>HbA1c</keyword>
  <keyword>Fructosamine</keyword>
  <keyword>Blood Pressure</keyword>
  <keyword>Telemonitoring</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
